W. Chang

First name
Middle name
Last name
. Y. Tan, Y., Papez, V., Chang, W. H., Mueller, S. H., Denaxas, S., & Lai, A. G. (2022). Comparing clinical trial population representativeness to real-world populations: an external validity analysis encompassing 43 895 trials and 5 685 738 individuals across 989 unique drugs and 286 conditions in England. Lancet Healthy Longev. http://doi.org/10.1016/s2666-7568(22)00186-6
Chang, W. H., Katsoulis, M., . Y. Tan, Y., Mueller, S. H., Green, K., & Lai, A. G. (2022). Late effects of cancer in children, teenagers and young adults: Population-based study on the burden of 183 conditions, in-patient and critical care admissions and years of life lost. Lancet Reg Health Eur, 12, 100248. http://doi.org/10.1016/j.lanepe.2021.100248
Lai, A. G., Pasea, L., Banerjee, A., Hall, G., Denaxas, S., Chang, W. H., et al. (2020). Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study. BMJ Open. http://doi.org/10.1136/bmjopen-2020-043828